A Study to Evaluate the Efficacy and Safety of Bendamustine Hydrochloride Injection

NCT04569838 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Indolent B-Cell Non-Hodgkin's Lymphomas

Interventions

DRUG: Bendamustine hydrochloride injection

Sponsor

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.